# Low-grade B-cell non-Hodgkin lymphoma in the sternocleidomastoid muscle: a case report and review of literature

**Authors:** Guiping Peng, Xiang Wang, Miao Dai

PMC · DOI: 10.3389/fonc.2026.1723488 · Frontiers in Oncology · 2026-02-19

## TL;DR

A rare case of low-grade B-cell lymphoma in a neck muscle is reported, highlighting the need for detailed testing for accurate diagnosis.

## Contribution

This is the first reported case of low-grade B-cell NHL in the sternocleidomastoid muscle.

## Key findings

- A 67-year-old male had a slowly growing neck mass diagnosed as low-grade B-cell NHL.
- Immunohistochemistry and molecular testing confirmed extranodal marginal zone lymphoma.
- The patient was managed with active surveillance due to the indolent nature of the disease.

## Abstract

Primary non-Hodgkin lymphoma (NHL) arising in skeletal muscle is exceedingly rare. We present a case of low-grade B-cell NHL involving the sternocleidomastoid muscle. A 67-year-old male presented with an asymptomatic, slowly growing left neck mass. Imaging revealed a 17 mm × 11 mm intramuscular nodule, initially suggestive of a benign lesion. Excisional biopsy demonstrated lymphoid proliferation with muscle infiltration. Immunohistochemistry revealed CD20(+), PAX5(+), BCL2(+), and monoclonal IgH rearrangement, consistent with low-grade B-cell NHL, most likely extranodal marginal zone lymphoma (ENMZL), non-gastric/non-cutaneous type. Staging confirmed Lugano stage I disease. Given the indolent nature, the patient was managed with active surveillance. This case highlights an unusual intramuscular presentation of NHL, emphasizing the importance of histopathological and molecular evaluation for accurate diagnosis and tailored management.

## Linked entities

- **Proteins:** MS4A1 (membrane spanning 4-domains A1), PAX5 (paired box 5), BCL2 (BCL2 apoptosis regulator)
- **Diseases:** non-Hodgkin lymphoma (MONDO:0018908)

## Full-text entities

- **Genes:** CCND1 (cyclin D1) [NCBI Gene 595] {aka BCL1, D11S287E, PRAD1, U21B31}, CD5 (CD5 molecule) [NCBI Gene 921] {aka LEU1, T1}, SDC1 (syndecan 1) [NCBI Gene 6382] {aka CD138, SDC, SYND1, syndecan}, SOX11 (SRY-box transcription factor 11) [NCBI Gene 6664] {aka CSS9, IDDMOH, MRD27}, CD19 (CD19 molecule) [NCBI Gene 930] {aka B4, CVID3}, PWWP3A (PWWP domain containing 3A, DNA repair factor) [NCBI Gene 84939] {aka EXPAND1, HSPC211, MUM-1, MUM1}, CMPK1 (cytidine/uridine monophosphate kinase 1) [NCBI Gene 51727] {aka CK, CMK, CMPK, UMK, UMP-CMPK, UMPK}, CR2 (complement C3d receptor 2) [NCBI Gene 1380] {aka C3DR, CD21, CR, CVID7, SLEB9}, FCER2 (Fc epsilon receptor II) [NCBI Gene 2208] {aka BLAST-2, CD23, CD23A, CLEC4J, FCE2, FCErII}, CD22 (CD22 molecule) [NCBI Gene 933] {aka SIGLEC-2, SIGLEC2}, IGH (immunoglobulin heavy locus) [NCBI Gene 3492] {aka IGD1, IGH.1@, IGH@, IGHD@, IGHDY1, IGHJ}, IGHD (immunoglobulin heavy constant delta) [NCBI Gene 3495], CD79A (CD79a molecule) [NCBI Gene 973] {aka IGA, IGAlpha, MB-1, MB1}, TNFRSF8 (TNF receptor superfamily member 8) [NCBI Gene 943] {aka CD30, D1S166E, Ki-1}, MME (membrane metalloendopeptidase) [NCBI Gene 4311] {aka CALLA, CD10, CMT2T, NEP, SCA43, SFE}, MYC (MYC proto-oncogene, bHLH transcription factor) [NCBI Gene 4609] {aka MRTL, MYCC, bHLHe39, c-Myc}, BCL2 (BCL2 apoptosis regulator) [NCBI Gene 596] {aka Bcl-2, PPP1R50}, KRT20 (keratin 20) [NCBI Gene 54474] {aka CD20, CK-20, CK20, K20, KRT21}, BCL6 (BCL6 transcription repressor) [NCBI Gene 604] {aka BCL5, BCL6A, LAZ3, ZBTB27, ZNF51}, PAX5 (paired box 5) [NCBI Gene 5079] {aka ALL3, BSAP, PAX-5}
- **Diseases:** hemangioma (MESH:D006391), sarcoma (MESH:D012509), B-cell lymphoproliferative disorder (MESH:D015448), fever (MESH:D005334), mantle cell lymphoma (MESH:D020522), DLBCL (MESH:D016403), B-cell NHL (MESH:D016393), EBV-driven lymphoproliferative disorders (MESH:D008232), intramuscular lymphomas (MESH:D008223), lymphadenopathy (MESH:D008206), NHL (MESH:D008228), myositis (MESH:D009220), neoplasia (MESH:D009369), reactive lymphoid hyperplasia (MESH:D019310), Lugano stage I disease (MESH:D007676), benign vascular lesion (MESH:D014652), weight loss (MESH:D015431), ENMZL (MESH:D018442), neck mass (MESH:D006258), follicular lymphoma (MESH:D008224), malignant muscle tumors (MESH:D019042), CLL/ (MESH:D015451)
- **Chemicals:** hematoxylin (MESH:D006416)
- **Species:** Homo sapiens (human, species) [taxon 9606], Coturnix coturnix (Common quail, species) [taxon 9091]
- **Cell lines:** ENMZL — Homo sapiens (Human), Prostate carcinoma, Telomerase immortalized cell line (CVCL_UZ14)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12960165/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12960165/full.md

## References

14 references — full list in the complete paper: https://tomesphere.com/paper/PMC12960165/full.md

---
Source: https://tomesphere.com/paper/PMC12960165